Ozoralizumab Completed Phase 3 Trials for Rheumatoid Arthritis Treatment

IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04077567An Extension Study of TS-152 in Subjects With Rheumatoid Arthritis